<DOC>
	<DOCNO>NCT00219804</DOCNO>
	<brief_summary>The primary objective study establish absolute reduction chorea participant Huntington 's disease ( HD ) treat tetrabenazine placebo</brief_summary>
	<brief_title>Efficacy Safety Tetrabenazine Chorea</brief_title>
	<detailed_description />
	<mesh_term>Huntington Disease</mesh_term>
	<mesh_term>Tetrabenazine</mesh_term>
	<criteria>18 year age old suffer manifest HD confirm genetic test Meet chorea total functional capacity score Unified Huntington 's Disease Rating Scale Meet criterion Hamilton Depression Rating Scale , Unified Parkinson 's Disease Rating Scale dysphagia dysarthria scale Independently ambulatory Exclusion Criteria previous treatment tetrabenazine unstable serious medical psychiatric illness concomitant use identify drug untreated depression lack caregiver</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>